Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacological therapies for autism spectrum disorder: a review.

Literature DB >> 26045648

Pharmacological therapies for autism spectrum disorder: a review.

Abstract

Medications are often added to behavioral therapy to help patients with autism spectrum disorder function successfully. This review discusses approved and off-label pharmacotherapeutic options for the various symptoms of the disorder.

Entities: Disease Species

Year: 2015 PMID： 26045648 PMCID： PMC4450669

Source DB: PubMed Journal: P T ISSN： 1052-1372

38 in total

1. Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis.

Authors: Akanksha Sharma; Steven R Shaw
Journal: J Pediatr Health Care Date: 2011-03-17 Impact factor: 1.812

2. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

Authors: David J Posey; Michael G Aman; James T McCracken; Lawrence Scahill; Elaine Tierney; L Eugene Arnold; Benedetto Vitiello; Shirley Z Chuang; Mark Davies; Yaser Ramadan; Andrea N Witwer; Naomi B Swiezy; Pegeen Cronin; Bhavik Shah; Deirdre H Carroll; Christopher Young; Courtney Wheeler; Christopher J McDougle
Journal: Biol Psychiatry Date: 2007-02-15 Impact factor: 13.382

3. Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms.

Authors: Giuliana Galli Carminati; Nicolas Deriaz; Gilles Bertschy
Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2005-11-22 Impact factor: 5.067

Review 4. Secretin: a pleiotrophic hormone.

Authors: J Y S Chu; W H Yung; B K C Chow
Journal: Ann N Y Acad Sci Date: 2006-07 Impact factor: 5.691

Review 5. Melatonin: a sleep-promoting hormone.

Authors: I V Zhdanova; H J Lynch; R J Wurtman
Journal: Sleep Date: 1997-10 Impact factor: 5.849

6. Oxytocin enhances brain function in children with autism.

Authors: Ilanit Gordon; Brent C Vander Wyk; Randi H Bennett; Cara Cordeaux; Molly V Lucas; Jeffrey A Eilbott; Orna Zagoory-Sharon; James F Leckman; Ruth Feldman; Kevin A Pelphrey
Journal: Proc Natl Acad Sci U S A Date: 2013-12-02 Impact factor: 11.205

7. Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder. An open label maintenance study.

Authors: Ozlem Gencer; F Neslihan Inal Emiroglu; Suha Miral; Burak Baykara; Aysen Baykara; Eray Dirik
Journal: Eur Child Adolesc Psychiatry Date: 2008-06 Impact factor: 4.785

8. Haloperidol for sedation of disruptive emergency patients.

Authors: J E Clinton; S Sterner; Z Stelmachers; E Ruiz
Journal: Ann Emerg Med Date: 1987-03 Impact factor: 5.721

9. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

Authors: Adam J Guastella; Stewart L Einfeld; Kylie M Gray; Nicole J Rinehart; Bruce J Tonge; Timothy J Lambert; Ian B Hickie
Journal: Biol Psychiatry Date: 2009-11-07 Impact factor: 13.382

Review 10. Drug therapy in autism: a present and future perspective.

Authors: Baldeep Kumar; Ajay Prakash; Rakesh K Sewal; Bikash Medhi; Manish Modi
Journal: Pharmacol Rep Date: 2012 Impact factor: 3.024

28 in total

Review 1. Neurobehavioral changes arising from early life dopamine signaling perturbations.

Authors: Lorena B Areal; Randy D Blakely
Journal: Neurochem Int Date: 2020-04-20 Impact factor: 3.921

Review 2. Hyperbaric oxygen therapy for children with autism spectrum disorder.

Authors: Teeranai Sakulchit; Chris Ladish; Ran D Goldman
Journal: Can Fam Physician Date: 2017-06 Impact factor: 3.275

3. A modified ketogenic gluten-free diet with MCT improves behavior in children with autism spectrum disorder.

Authors: Ryan W Y Lee; Michael J Corley; Alina Pang; Gaye Arakaki; Lisa Abbott; Michael Nishimoto; Rob Miyamoto; Erica Lee; Susan Yamamoto; Alika K Maunakea; Annette Lum-Jones; Miki Wong
Journal: Physiol Behav Date: 2018-02-05

Review 4. Behavioral Approaches to Assessment and Early Intervention for Severe Problem Behavior in Intellectual and Developmental Disabilities.

Authors: Patricia F Kurtz; Mauro Leoni; Louis P Hagopian
Journal: Pediatr Clin North Am Date: 2020-05-04 Impact factor: 3.278

Review 5. Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors: Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal: Mol Neurobiol Date: 2018-01-06 Impact factor: 5.590

Review 6. A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.

Authors: Sushmitha S Purushotham; Neeharika M N Reddy; Michelle Ninochka D'Souza; Nilpawan Roy Choudhury; Anusa Ganguly; Niharika Gopalakrishna; Ravi Muddashetty; James P Clement
Journal: Exp Brain Res Date: 2022-09-05 Impact factor: 2.064

Review 7. Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications.

Authors: Chen-Chen Jiang; Li-Shan Lin; Sen Long; Xiao-Yan Ke; Kohji Fukunaga; Ying-Mei Lu; Feng Han
Journal: Signal Transduct Target Ther Date: 2022-07-11

8. A Pilot Study: Parent Perceptions of Behavior Change in Their Child With Autism Spectrum Disorder Following High Antioxidant Cacao Consumption.

Authors: Amy Sadek; Lee S Berk; Karen Mainess; Noha S Daher
Journal: Integr Med (Encinitas) Date: 2018-10

9. Prescription Drug Use and Polypharmacy Among Medicaid-Enrolled Adults with Autism: A Retrospective Cross-Sectional Analysis.

Authors: Rini Vohra; Suresh Madhavan; Usha Sambamoorthi; Claire StPeter; Susannah Poe; Nilanjana Dwibedi; Mayank Ajmera
Journal: Drugs Real World Outcomes Date: 2016-12

Review 10. Prediction of response to drug therapy in psychiatric disorders.

Authors: Shani Stern; Sara Linker; Krishna C Vadodaria; Maria C Marchetto; Fred H Gage
Journal: Open Biol Date: 2018-05 Impact factor: 6.411